SSRI antidepressants for adolescents: Professor Werry replies to Medsafe.
Werry
John S
JS
D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D003866:Depressive Disorder / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D009520:New Zealand; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors